Natixis Inovio Pharmaceuticals, Inc. Transaction History

Natixis

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$7.16 - $9.69 $473,276 - $640,509	-66,100 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.23 - $10.03 $411,803 - $662,983	66,100 New	66,100 $613,000
Q1 2021 May 14, 2021	SELL	$8.81 - $16.96 $154,175 - $296,800	-17,500 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$8.5 - $12.85 $148,750 - $224,875	17,500 New	17,500 $155,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.19B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.